Abstract: The present invention relates to a motor driving control system and a control method thereof. The purpose of the present invention is to provide a motor driving control system and a control method thereof, which may change electric current limiting logic, which is applied to a BLDC motor for a cooling fan, in response to an operating speed of the motor to stably protect the motor from an overload in a low-speed driving state as well as an overload in a high-speed driving state.

Abstract: A method for preparing error recovery of a memory device included in a memory system includes performing a training operation of the memory device upon power-on of the memory system, booting an operating system into a normal mode by operating the memory device using a selected operation frequency of a plurality of operation frequencies based on results of the training operation, detecting an error frequency among the plurality of operation frequencies in response to a change of the selected operation frequency of the memory device by the operating system, the error frequency being an operation frequency which causes at least one error in the memory device, and storing information regarding the detected error frequency in a first register included in a memory controller associated with the memory device.

Abstract: Disclosed are a vehicle including an electric motor and a method of controlling the same for providing a notification function to an occupant of the vehicle by controlling a pitching motion of a vehicle body. The method includes calculating a first torque value for providing the pitching motion based on driving state information including a vehicle speed, a driving mode, and an environment of a driving road; calculating a second torque value based on a request of a driver; and calculating a final torque value for controlling the electric motor based on the first torque value and the second torque value.

Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises any one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide that has at least one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptides of this invention can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: In a method for recovering lithium hydroxide from a lithium secondary battery, cathode powder is prepared from a cathode of the lithium secondary battery. A cathode active material mixture is prepared by mixing the cathode powder with a calcium compound. The cathode active material mixture is reduced to form a preliminary precursor mixture. A lithium precursor is recovered from the preliminary precursor mixture. Therefore, a lithium precursor can be obtained with high purity without a complicated leaching process or an additional process, which result from a wet-based acid solution process.

Abstract: Provided is an atypical environment-based location recognition apparatus. The apparatus includes a sensing information acquisition unit configured to, from sensing data collected by sensor modules, detect object location information and semantic label information of a video image and detect an event in the video image; a walk navigation information provision unit configured to acquire user movement information; a metric map generation module configured to generate a video odometric map using sensing data collected through a sensing information acquisition unit and reflect the semantic label information; and a topology map generation module configured to generate a topology node using sensing data acquired through the sensing information acquisition unit and update the topology node through the collected user movement information.

Abstract: A moving display device disposed in a vehicle includes a display configured to be moveable in a forward or backward direction according to a driving mode of a vehicle, and a moving device mounted on a rear of the display and being configured to move a position of the display and to tilt the display, wherein the moving device includes rails, actuators, and gear modules for forward or backward movement of the display.

Abstract: The present invention relates to a novel naphthyridinone derivative compound, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a stereoisomer thereof, which are each relevant to a compound for inhibiting ENPP1, a composition for inhibiting ENPP1, and a method for inhibiting ENPP1.

Abstract: An actuator is proposed. A housing and a housing cap constitute an exterior of the actuator, and a driving pin is installed by passing through an inner space of the housing such that the driving pin moves rectilinearly. A permanent magnet and an outer iron core are stacked and installed at the inner surface of the housing, that is, in the inner space. The permanent magnets and the outer iron core are stacked such that a set of permanent magnet and outer iron core in which the permanent magnet is stacked at each of opposite sides of one outer iron core.

Abstract: Disclosed are airbag integrated moving display and a control method where the airbag-integrated display includes a display movable to a forward or rearward position according to a driving mode of a vehicle, and an airbag mounted to the rear of the display and being configured to move along with a movement of the display, vary a level of inflation of the airbag based on at least one of a position of the display or a distance from a driver of the vehicle.

Abstract: A battery bank control device is provided for setting a power limit value of a battery bank in which a plurality of battery racks (BRs) are connected in parallel. The device includes: a voltage measurement unit measuring a voltage of each BR of the plurality of BRs; a first power limit calculation unit calculating a first power limit value according to a state of charge (SOC) calculated based on the voltage of each BR with respect to each BR; a capacity ratio calculation unit calculating a capacity ratio of each BR based on capacity information of the plurality of BRs; a second power limit calculation unit calculating a second power limit value using the capacity ratio and the first power limit value of each BR; and a battery bank power limit calculation unit calculating a battery bank power limit value using the second power limit value of each BR.

Abstract: The present invention relates to a novel benzotriazole derivative compound, a tautomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a stereoisomer thereof, which are related to a compound for inhibiting ENPP1, a composition for inhibiting ENPP1, and a method for inhibiting ENPP1.

Abstract: Proposed are a seat side bolster apparatus and a control method thereof. The seat side bolster apparatus of the disclosure includes a driving unit, which is provided under a foam pad of a seat cushion, is moved upwards and downwards by operation of an actuator, and presses the foam pad upwards when moving upwards, and a covering bracket, which is connected to the driving unit so as to be moved upwards and downwards together with the driving unit and to which an end of a covering enveloping the foam pad of the seat cushion is fixed.

Abstract: An antibacterial composition according to an exemplary embodiment of the present technology comprises one or more compounds comprising a quaternary ammonium structure having an acrylate group or a methacrylate group, in which a critical micelle concentration of the compound comprising the quaternary ammonium structure is 0.1 wt % to 3 wt %.

Abstract: Disclosed herein is a device for interlocking a display device with a vehicle, the device including a mount disposed in the vehicle, the display device being attached to and detached from the mount, a first sliding member disposed on a front surface of the mount and capable of moving forward or backward in a direction perpendicular to a rear surface of the display device, and a connector provided to the first sliding member, wherein the connector may transmit and receive electrical signals to and from the display device. The vehicle may be controlled by coupling a display device to the interlocking device disposed in the vehicle. Even when the display device is not coupled to the vehicle, the vehicle may be controlled by pairing through wireless communication between the vehicle and the display device.

Abstract: A display device includes a pixel in a display area. The pixel includes a first electrode and a second electrode that are spaced apart from each other, a first insulating layer disposed on the first and second electrodes and including a trench corresponding to a region between the first and second electrodes, light emitting elements disposed in the trench, each of the light emitting elements including a first end portion and a second end portion, a first contact electrode disposed on the first end portion of each of the light emitting elements and the first electrode, and a second contact electrode disposed on the second end portion of each of the light emitting elements and the second electrode. The trench includes a first trench accommodating the light emitting elements, and second trenches disposed in the first trench.

Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises SEQ ID NO: 1, the peptide has above 80% homology of amino acid sequence with above-mentioned sequence, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide comprising a sequence of SEQ ID NO: 1 has an outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptide of this invention can be used as anti-inflammatory pharmaceutical composition or as cosmetic composition, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: A composition for promoting mitochondrial biogenesis includes an effective amount of an azelaic acid or a pharmaceutically acceptable salt thereof as an active ingredient. Azelaic acid, which is a compound mainly contained in cereals and natural products has the advantage of no or little side effects, and induces mitochondrial autophagy and mitochondrial DNA synthesis in cells, thereby having activity of increasing mitochondrial density. Therefore, azelaic acid can be used for the treatment of mitochondrial dysfunction-associated disease caused by the failure of homeostasis control of the mitochondria, for example, mitochondrial activity or the decrease in the number of mitochondria.

Abstract: An aerosol generating device includes a heater configured to heat an aerosol generating material to generate aerosol; a controller configured to: calculate a current flowing through the heater based on a predefined resistance of the heater and power supplied to the heater, measure the current flowing through the heater, and control the power supplied to the heater based on a difference between the calculated current and the measured current.

Abstract: A capsulorhexis device is inserted into an incision site of a cornea to make an incision in an anterior capsule surrounding a crystalline lens. The capsulorhexis device includes a loop having elasticity and conductivity; a moving member having one end fixed and coupled to the loop; an insertion guide configured so that, while the incision is being made in the crystalline lens capsule, a front end thereof is inserted into the incision site of the cornea; and a housing having one end coupled to a rear end of the insertion guide, wherein the loop is housed in the housing and, to make the incision in the crystalline lens capsule, slides in the housing together with the moving member to pass through the insertion guide and be deployed into an anterior chamber of the eye.